Predictive Value of Immunologic and Virologic Markers After Long or Short Duration of HIV‐1 Infection
暂无分享,去创建一个
John W. Mellors | Robert H. Lyles | Traci E. Yamashita | Roger Detels | J. Margolick | J. Phair | R. Detels | J. Mellors | C. Rinaldo | J. Giorgi | R. Lyles | J. Matud | L. Hultin | B. Jamieson | John P. Phair | Beth D. Jamieson | Charles R. Rinaldo | Joseph B. Margolick | Janis V. Giorgi | Jose L. Matud | Lance E. Hultin | T. Yamashita
[1] M. Prins,et al. Early and late HIV‐1 RNA level and its association with other markers and disease progression in long‐term AIDS‐free homosexual men , 1997, AIDS.
[2] J. Lundgren,et al. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome , 1996, AIDS.
[3] J. Phair,et al. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. , 1987, American journal of epidemiology.
[4] B. Clotet,et al. Lack of evidence of a stable viral load set‐point in early stage asymptomatic patients with chronic HIV‐1 infection , 1998, AIDS.
[5] R. Detels,et al. Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T‐cell measurements , 1998, AIDS.
[6] R. Detels,et al. CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[7] J J Goedert,et al. Natural history of HIV-1 cell-free viremia. , 1995, JAMA.
[8] A. Fauci,et al. The immunopathogenesis of human immunodeficiency virus infection. , 1993, The New England journal of medicine.
[9] J. Margolick,et al. Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program. , 1993, Cytometry.
[10] R H Lyles,et al. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. , 2000, The Journal of infectious diseases.
[11] J V Giorgi,et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. , 1999, The Journal of infectious diseases.
[12] J. Margolick,et al. Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience. The Multicenter AIDS Cohort Study Group. , 1990, Clinical immunology and immunopathology.
[13] R. Brookmeyer,et al. Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. , 1987, American journal of epidemiology.
[14] J. Margolick,et al. Effects of Anticoagulant, Processing Delay, and Assay Method (Branched DNA versus Reverse Transcriptase PCR) on Measurement of Human Immunodeficiency Virus Type 1 RNA Levels in Plasma , 1999, Journal of Clinical Microbiology.
[15] A. Muñoz,et al. Models for the incubation of AIDS and variations according to age and period. , 1996, Statistics in medicine.
[16] P. Harrigan,et al. Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV type 1-infected persons. , 1997, AIDS research and human retroviruses.
[17] J. Goedert,et al. Plasma HIV Viral Load in Patients with Hemophilia and Late-Stage HIV Disease: A Measure of Current Immune Suppression , 1999, Annals of Internal Medicine.
[18] J V Giorgi,et al. Quantitation of CD38 activation antigen expression on CD8+ T cells in HIV-1 infection using CD4 expression on CD4+ T lymphocytes as a biological calibrator. , 1998, Cytometry.
[19] Roger Detels,et al. Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.
[20] J. Chmiel,et al. Estimation of time since exposure for a prevalent cohort. , 1992, Statistics in medicine.